A DECISION MODELING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH PLANNED PERCUTANEOUS CORONARY INTERVENTION

被引:1
|
作者
Rao, S. [1 ]
Lin, F. J. [1 ]
Ojo, O. [1 ]
Patel, V [1 ]
Yu, S. [1 ]
Zhan, L. [1 ]
Touchette, D. R. [1 ]
机构
[1] Univ Illinois, Chicago, IL USA
关键词
D O I
10.1016/j.jval.2011.02.229
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A39 / A40
页数:2
相关论文
共 50 条
  • [21] Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
    Grima, Daniel T.
    Brown, Stephen T.
    Kamboj, Laveena
    Bainey, Kevin R.
    Goeree, Ron
    Oh, Paul
    Ramanathan, Krishnan
    Goodman, Shaun G.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 49 - 62
  • [22] Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: The TRITON-TIMI 38 Study
    Antman, Elliott M.
    CIRCULATION, 2007, 116 (22) : 2628 - 2628
  • [24] Effectiveness and Safety of Prasugrel/Clopidogrel Therapy Versus Clopidogrel Therapy in Patients Who Have Undergone Percutaneous Coronary Intervention: A Real-World Experience in Central India
    Rao, Roshan
    Rao, Sarita
    Kumar, Achukatla
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (04) : S15 - S15
  • [25] Impact and use of prasugrel versus Clopidogrel as a function of age among patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Chandrasekhar, J.
    Baber, U.
    Sartori, S.
    Aquino, M.
    Henry, T.
    Rao, S.
    Snyder, C.
    Weintraub, W.
    Effron, M.
    Pocock, S.
    Keller, S.
    Kini, A.
    Strauss, C.
    Mehran, R.
    Kapadia, S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1164 - 1164
  • [26] Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients
    Stroupe, Kevin T.
    Morrison, Douglass A.
    Hlatky, Mark A.
    Barnett, Paul G.
    Cao, Lishan
    Lyttle, Christopher
    Hynes, Denise M.
    Henderson, William G.
    CIRCULATION, 2006, 114 (12) : 1251 - 1257
  • [27] CORONARY BYPASS SURGERY VERSUS PERCUTANEOUS CORONARY INTERVENTION: COST-EFFECTIVENESS IN IRAN: A STUDY IN PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE
    Javanbakht, Mehdi
    Bakhsh, Razieh Yazdani
    Mashayekhi, Atefeh
    Ghaderi, Hossein
    Sadeghi, Masoumeh
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (04) : 366 - 373
  • [28] USE OF CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: FACTORS INFLUENCING REAL-WORLD THERAPEUTIC DECISION-MAKING
    Salianski, Olga
    Baber, Usman
    Sartori, Samantha
    Aquino, Melissa
    Chandrasekhar, Jaya
    Kini, Annapoorna
    Rao, Sunil
    Weintraub, William
    Weiss, Sandra
    Henry, Timothy
    Kapadia, Samir
    Poddar, Kanhaiya
    DeFranco, Anthony
    Muhlestein, J.
    Toma, Catalin
    Effron, Mark
    Keller, Stuart
    Baker, Brian
    Pocock, Stuart
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 184 - 184
  • [29] Cost-effectiveness analysis of genotype-guided antiplatelet therapy in patients with acute coronary syndrome and planned percutaneous coronary intervention.
    Lin, Fang-Ju
    Patel, Vardhaman
    Ojo, Olaitan
    Rao, Sapna
    Yu, Shengsheng
    Zhan, Lin
    Touchette, Daniel R.
    PHARMACOTHERAPY, 2012, 32 (10): : E300 - E300
  • [30] Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective
    Osnabrugge, Ruben L.
    Magnuson, Elizabeth A.
    Serruys, Patrick W.
    Campos, Carlos M.
    Wang, Kaijun
    van Klaveren, David
    Farooq, Vasim
    Abdallah, Mouin S.
    Li, Haiyan
    Vilain, Katherine A.
    Steyerberg, Ewout W.
    Morice, Marie-Claude
    Dawkins, Keith D.
    Mohr, Friedrich W.
    Kappetein, A. Pieter
    Cohen, David J.
    HEART, 2015, 101 (24) : 1980 - 1988